From: Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients
Outcome | Median follow-up (range)* | Events/Total | Model | HR | 95% CI | p |
---|---|---|---|---|---|---|
Disease Free Survival (DFS) | 39.88 (21.17 – 58.77) | 34/90 | Univariable | 1.16 | 1.02-1.31 | 0.021 |
31/79 | Multivariable | 1.30 | 1.11-1.51 | <0.001 | ||
Metastasis-Free Survival (MFS) | 43.57 (25.23 – 59.77) | 30/90 | Univariable | 1.17 | 1.03-1.34 | 0.019 |
27/79 | Multivariable | 1.34 | 1.13-1.59 | <0.001 | ||
Overall Survival (OS) | 45.78 (32.60 – 60.50) | 18/90 | Univariable | 1.20 | 1.04-1.38 | 0.015 |
16/79 | Multivariable | 1.31 | 1.10-1.57 | 0.003 |